RM

Ramanuj Mishra

Director Director DIN 05172507
DIN 05172507 First appointment Jan 2012 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramanuj Mishra

Data last updated:

Ramanuj Mishra was a Director at Unicorn Life Sciences Private Limited (2012–2013) and Director at Vpraa Pharmaceuticals Private Limited (from 2013). The companies operate in Chemicals.

DIN 05172507
Primary Designation Director
Industry Chemicals
First Appointment 23 Jan 2012
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jan 20122012Strike Off
Director01 May 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vpraa Pharmaceuticals Private Limited
Unicorn Life Sciences Private Limited
Premium access

Shareholding and investment profile for Ramanuj Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramanuj Mishra

Ramanuj Mishra was first appointed on 23 Jan 2012 as Director at Unicorn Life Sciences Private Limited. The most recent appointment on record is 01 May 2013 at Vpraa Pharmaceuticals Private Limited.

Ramanuj Mishra held 2 earlier board appointments: Unicorn Life Sciences Private Limited (Director, 23 Jan 2012 to 14 Apr 2013); Vpraa Pharmaceuticals Private Limited (Director, from 01 May 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available